Home
Create Account
Login
Please don't use dangerous characters
Title
Author
Abstract
Keywords
First Name
Last Name
Search
ISSN
:
2322-5939
×
International Journal of Health Policy and Management
Original Article
1. How Are New Vaccines Prioritized in Low-Income Countries? A Case Study of Human Papilloma Virus Vaccine and Pneumococcal Conjugate Vaccine in Uganda
Lauren Wallace, Lydia Kapirir*
Int J Health Policy Manag
. 2017;6(12): 707-720.
doi:
10.15171/ijhpm.2017.37
PMCID:
PMC5726321
PMID:
29172378
Article
PDF
XML
Cited By:
×
How Are New Vaccines Prioritized in Low-Income Countries? A Case Study of Human Papilloma Virus Vaccine and Pneumococcal Conjugate Vaccine in Uganda
Commentary
2. Vaccines, Politics and Mandates: Can We See the Forest for the Trees? Comment on “Convergence on Coercion: Functional and Political Pressures as Drivers of Global Childhood Vaccine Mandates”
Noni E. MacDonald*
, Ève Dubé, Jeannette Comeau
Int J Health Policy Manag
. 2023;12: 7572 | Published on: 2022 Oct 22.
doi:
10.34172/ijhpm.2022.7572
PMCID:
PMC10125092
PMID:
36404500
Article
PDF
XML
Cited By:
×
Vaccines, Politics and Mandates: Can We See the Forest for the Trees? Comment on “Convergence on Coercion: Functional and Political Pressures as Drivers of Global Childhood Vaccine Mandates”
Original Article
3. Biopharmaceutical Financialization and Public Funding of Medical Countermeasures (MCMs) in Canada During the COVID-19 Pandemic
Ipek Eren Vural*
, Matthew Herder
, Agnieszka Doll
, Janice E. Graham
Int J Health Policy Manag
. 2023;12: 6936 | Published on: 2023 May 27.
doi:
10.34172/ijhpm.2023.6936
PMCID:
PMC10462233
PMID:
37579382
Article
PDF
Suppl 1
Suppl 2
Suppl 3
XML
Cited By:
×
Biopharmaceutical Financialization and Public Funding of Medical Countermeasures (MCMs) in Canada During the COVID-19 Pandemic
Submit Your Paper
Archive
